Addus Homecare Revenue Growth Rates (ADUS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Addus Homecare Corp  (NASDAQ: ADUS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

ADUS's Revenue Growth by Quarter and Year

Addus Homecare's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ADUS/growth
https://api.csimarket.com/api/v1/companies/ADUS/fundamentals
https://api.csimarket.com/api/v1/companies/ADUS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
ADUS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 387.73
2nd Quarter June 377.42
1st Quarter March 362.87
FY 1,128.02

ADUSs Annual Revenue
Addus Homecare's Revenue in the fiscal year 2025 $ 1,421.87 millions
Addus Homecare's Revenue in the fiscal year 2024 $ 1,154.02 millions
Addus Homecare's Revenue in the fiscal year 2023 $ 1,057.88 millions
Addus Homecare's Revenue in the fiscal year 2022 $ 951.12 millions
Addus Homecare's Revenue in the fiscal year 2021 $ 864.50 millions




ADUS Revenue third quarter 2026 Y/Y Growth Comment
Addus Homecare Corp reported Revenue growth of 7.19% year on year in the third quarter 2026, to $ 387.73 millions, this is lower than Addus Homecare Corp's recent average Revenue increase of 10.34%.

Looking into third quarter 2026 results within Healthcare Facilities industry 12 other companies have achieved higher Revenue growth. While Addus Homecare Corp' s Revenue increase of 7.19% ranks overall at the positon no. 1928 in the third quarter 2026.


ADUS Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 7.19 %
2nd Quarter June 8.18 %
1st Quarter March 7.46 %
FY   -

Financial Statements
Addus Homecare's third quarter 2026 Revenue $ 387.73 millions ADUS's Income Statement
Addus Homecare's third quarter 2025 Revenue $ 361.72 millions Quarterly ADUS's Income Statement


ADUS Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 2.73 %
2nd Quarter June 4.01 %
1st Quarter March -2.87 %
FY (Year on Year)   -


Back to ADUS Growth rate Comparisons >> Back to ADUS Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #13
Healthcare Sector #293
Overall #1928

Revenue Y/Y Growth Statistics
High Average Low
99.07 % 10.34 % -100 %
(Sep 30 2014)  
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #13
Healthcare Sector #293
Overall #1928
Revenue Y/Y Growth Statistics
High Average Low
99.07 % 10.34 % -100 %
(Sep 30 2014)  

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Addus Homecare's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
79.46 % 3.86 % -50.56 %
(Mar 31 2013)  


ADUS's III. Quarter Q/Q Revenue Comment
Addus Homecare Corp achieved in the III. Quarter 2026 below company average Revenue growth of 2.73% quarter on quarter, to $ 387.73 millions.

Within Healthcare Facilities industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Addus Homecare's Revenue growth quarter on quarter, overall rank is 1213.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #177
Overall #1213
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #177
Overall #1213
Revenue Q/Q Growth Statistics
High Average Low
79.46 % 3.86 % -50.56 %
(Mar 31 2013)  


ADUS's III. Quarter Q/Q Revenue Comment
Addus Homecare Corp achieved in the III. Quarter 2026 below company average Revenue growth of 2.73% quarter on quarter, to $ 387.73 millions.

Within Healthcare Facilities industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Addus Homecare's Revenue growth quarter on quarter, overall rank is 1213.


Addus Homecare's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1,475.61
Y / Y Revenue Growth (TTM) 15.8 %
Year on Year Revenue Growth Overall Ranking # 1140
Seqeuential Revenue Change (TTM) 1.97 %
Seq. Revenue Growth (TTM) Overall Ranking # 2054


Cumulative Revenue growth Comment
Assuming the Addus Homecare's fiscal year would have ended in Jun 30 2026, Addus Homecare would have reprted above average annual Revenue increase of 15.8% year on year, of $ 1,476 millions.
This marks a slow-down of the companys growth trends and from the 19.44% rise in Mar 31 2026.

In the Healthcare sector 210 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1102 to 1140.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 23
Healthcare Sector # 211
Overall # 1140

Revenue TTM Y/Y Growth Statistics
High Average Low
29.86 %
 14.69 %
-13.59 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 312
S&P 500 # 2054
Cumulative Revenue growth Comment
Assuming the Addus Homecare's fiscal year would have ended in Jun 30 2026, Addus Homecare would have reprted above average annual Revenue increase of 15.8% year on year, of $ 1,476 millions.
This marks a slow-down of the companys growth trends and from the 19.44% rise in Mar 31 2026.

In the Healthcare sector 210 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1102 to 1140.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 23
Healthcare Sector # 211
Overall # 1140

Revenue TTM Y/Y Growth Statistics
High Average Low
29.86 %
14.69 %
-13.59 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 312
S&P 500 # 2054




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ADUS's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Medicinova Inc 12.35%$ 12.355 millions
Bionano Genomics Inc 12.34%$ 12.339 millions
Viemed Healthcare Inc 12.18%$ 12.180 millions
Ufp Technologies Inc 12.15%$ 12.154 millions
Innovage Holding Corp 12.14%$ 12.135 millions
Vertex Pharmaceuticals Inc11.85%$ 11.845 millions
Sanara Medtech Inc 11.67%$ 11.668 millions
Lemaitre Vascular Inc 11.51%$ 11.508 millions
Pacs Group Inc 11.45%$ 11.454 millions
Ocugen Inc 11.36%$ 11.358 millions
Dexcom Inc 11.26%$ 11.263 millions
Elanco Animal Health Incorporated11.26%$ 11.258 millions
Koru Medical Systems Inc 11.19%$ 11.194 millions
Elite Pharmaceuticals Inc 11.11%$ 11.113 millions
Pro dex Inc 10.96%$ 10.955 millions
Nrc Health10.95%$ 10.954 millions
Anika Therapeutics Inc 10.91%$ 10.912 millions
Harvard Bioscience Inc 10.86%$ 10.864 millions
Repligen Corp10.86%$ 10.863 millions
Warby Parker Inc 10.77%$ 10.767 millions
Cerus Corporation10.69%$ 10.690 millions
Biogen Inc 10.63%$ 10.628 millions
Chemed Corporation10.57%$ 10.568 millions
Edwards Lifesciences Corporation10.47%$ 10.471 millions
Biodesix Inc 10.44%$ 10.442 millions
Medline Inc 10.41%$ 10.415 millions
Jazz Pharmaceuticals Plc10.38%$ 10.380 millions
Abbvie Inc 10.32%$ 10.319 millions
Livanova Plc10.17%$ 10.170 millions
Kura Oncology Inc 10.07%$ 10.067 millions


About Addus Homecare Revenue Growth Rates (ADUS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Addus Homecare Corp (CIK 1468328).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-034965
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Addus Homecare Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.